Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Hyaluronic Acid and Triamcinolone Acetonide for Subdeltoid Bursitis
NCT06935877Phase 4Not yet recruiting
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of triamcinolone acetonide in subdeltoid bursitis, sponsored by Shin Kong Wu Ho-Su Memorial Hospital. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
subdeltoid bursitis
Beyond the preview
Go deeper on NCT06935877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06935877.